SAHIL GARG

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology NEWNAN, GA NPI 1881942902

General Payments — all program years on this page

$4,251.13

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 35
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $167.16 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $120.325
Education $46.848

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $86.865
2020 $39.062
2021 $41.122
2022 $3,732.587
2023 $184.356
2024 $167.1613

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104301460 AstraZeneca Pharmaceuticals LP $25.92 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104501448 AstraZeneca Pharmaceuticals LP $22.92 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118214977 Boehringer Ingelheim Pharmaceuticals, Inc. $27.66 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149930042 Travere Therapeutics, Inc. $0.37 06/05/2024 Education Undisputed 01/23/2026 View at CMS
1149930046 Travere Therapeutics, Inc. $0.37 10/25/2024 Education Undisputed 01/23/2026 View at CMS
1149930050 Travere Therapeutics, Inc. $3.08 01/05/2024 Education Undisputed 01/23/2026 View at CMS
1149930054 Travere Therapeutics, Inc. $3.08 03/14/2024 Education Undisputed 01/23/2026 View at CMS
1149930058 Travere Therapeutics, Inc. $3.08 06/05/2024 Education Undisputed 01/23/2026 View at CMS
1149930061 Travere Therapeutics, Inc. $3.08 07/18/2024 Education Undisputed 01/23/2026 View at CMS
1149930065 Travere Therapeutics, Inc. $16.89 03/14/2024 Education Undisputed 01/23/2026 View at CMS
1149930069 Travere Therapeutics, Inc. $16.89 07/18/2024 Education Undisputed 01/23/2026 View at CMS
1150118489 SHIELD THERAPEUTICS INC $23.55 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150131036 SHIELD THERAPEUTICS INC $20.27 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.